Comparing Conservative Therapies for the Alleviation of Knee Pain in Knee Osteoarthritis
Prospective Randomized Controlled Trial Comparing Conservative Therapies for the Alleviation of Knee Pain in Knee Osteoarthritis
2 other identifiers
interventional
50
1 country
1
Brief Summary
Patients with chronic knee pain attributed to osteoarthritis and referred to orthopedics as potential candidates for a knee replacement will receive standard physiotherapy or myofascial-specific therapy over 8 weeks. Based on the investigators pilot investigation, the investigators expect those who receive myofascial-specific therapy to experience reduced pain (compared to the standard therapy group) and increased flexibility compared to baseline levels. This simple conservative therapy could postpone (or in some cases, eliminate) the need for a knee replacement since pain is the major indication for surgery. If successful, this treatment could improve the quality of life and increase productivity for thousands suffering from knee osteoarthritis and preserve valuable health care resources.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Sep 2013
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 2, 2014
CompletedFirst Posted
Study publicly available on registry
December 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedApril 6, 2018
April 1, 2018
2.8 years
December 2, 2014
April 4, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Pain scores on visual analogue scale (VAS)
8 weeks
Secondary Outcomes (8)
Brief pain inventory (BPI)
biweekly for 8 weeks, 3 months, 6 months
Oxford knee score
biweekly for 8 weeks, 3 months, 6 months
McGill short pain questionnaire
biweekly for 8 weeks, 3 months, 6 months
timed up and go (TUG)
Baseline, 3 months
6 minute walk test
Baseline, 3 months
- +3 more secondary outcomes
Study Arms (2)
standard physiotherapy
ACTIVE COMPARATORStandard of care physiotherapy for knee osteoarthritis (OA) patients who have been diagnosed with knee OA and may be candidates for total knee replacement (TKA)
Myofascial-specific therapy
EXPERIMENTALPatient undergo myofascial pain-specific therapy which includes trigger point injections at the same time points as the comparator (1 session every 2 weeks for 8 weeks)
Interventions
standard of care physiotherapy once every 2 weeks for 8 weeks
Once every 2 weeks for 8 weeks (includes trigger point injections if deemed 'necessary' by chronic pain physician)
Eligibility Criteria
You may qualify if:
- diagnosis of bi or unilateral knee OA
- knee pain attributed to knee OA
- referral to orthopedics as a potential candidate for knee total knee arthroplasty
- ability to comprehend/sign consent, independent mobility without assistive devices
You may not qualify if:
- allergy/contraindication to study medications (i.e., trigger point injections), previous knee replacement surgery
- infections of clinical abnormalities other than knee OA that could cause the knee pain
- other diagnosed chronic pain syndrome for which they are taking regular pain medications
- pregnancy or breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hotel Dieu Hospital
Kingston, Ontario, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Henry, MD, FRCPC
Queens University/Kingston General Hospital
- PRINCIPAL INVESTIGATOR
Gavin Wood, MD, FRCSC
Queens University/Kingston General Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 2, 2014
First Posted
December 19, 2014
Study Start
September 1, 2013
Primary Completion
July 1, 2016
Study Completion
December 1, 2016
Last Updated
April 6, 2018
Record last verified: 2018-04